Karyn Colman - Concepedia

Author

Karyn Colman

Novartis (United States)ORCID

Also Known As

Karyn A. Colman, Karyn Colman

Publications

880

Citations

H-Index

Concepts

All Affiliations

Novartis (United States)Boehringer Ingelheim (United States)GlaxoSmithKline (United States)Genomics Institute of the Novartis Research Foundation Pfizer (United States)

About

Karyn Colman is an author at Novartis (United States) specializing in medicine, pharmacology, and drug discovery.

Top Concepts

#	Concept	H-Index	Publications	Citations
1	Medicine	5	5	482
2	Health Sciences	1	1	13
3	Biochemistry	1	1	13
4	Biology	1	1	270
5	Diabetes	1	1	13

Karyn Colman

Publications

607

Citations

H-Index

Page 1

	Year	Citations
Phenotypic landscape of intestinal organoid regeneration Ilya Lukonin, Denise Serra, Ludivine Challet Meylan, Nature BiologyRegenerationRegenerative MedicinePhenotypic LandscapeIntestinal Transplantation	2020	270
An Analysis of Pharmaceutical Experience with Decades of Rat Carcinogenicity Testing Frank D. Sistare, Daniel Morton, Carl L. Alden, Toxicologic Pathology Chemoprevention StrategyPathologyToxicology TestingPharmacotherapyPharmacological Study	2011	152
Selective DYRK1A Inhibitor for the Treatment of Type 1 Diabetes: Discovery of 6-Azaindole Derivative GNF2133 Yahu A. Liu, Qihui Jin, Yefen Zou, Journal of Medicinal Chemistry	2020	74
International Harmonization of Nomenclature and Diagnostic Criteria (INHAND): Nonproliferative and Proliferative Lesions of the Dog Jochen Woicke, Muthafar Al-Haddawi, Jean-Guy Bienvenu, Toxicologic Pathology	2021	40
Endocardial Myxomatous Change in Harlan Sprague-Dawley Rats (Hsd:S—D) and CD-1 Mice: Its Microscopic Resemblance to Drug-Induced Valvulopathy in Humans Chandikumar S. Elangbam, Karyn Colman, Ruth M. Lightfoot, Toxicologic Pathology Cardiac MuscleHeart FailurePathologyCardiovascular ToxicityCd-1 Mice	2002	28
Tg.rasH2 Mouse Model for Assessing Carcinogenic Potential of Pharmaceuticals: Industry Survey of Current Practices Matthew S. Bogdanffy, Jacob Lesniak, Raja S. Mangipudy, International Journal of Toxicology Pharmaceutical ResearchTg.rash2 MouseDermatologyLaboratory Animal StudyTg.rash2 Model	2020	19
Utilization of the Zucker Diabetic Fatty (ZDF) Rat Model for Investigating Hypoglycemia-related Toxicities Mark A. Tirmenstein, Joseph Horvath, Michael J. Graziano, Toxicologic Pathology Metabolic DisorderInsulin SignalingRat ModelObesityMetabolic Syndrome	2015	13
Scientific and Regulatory Policy Committee Best Practices: Recommended (“Best”) Practices for Informed (Non-blinded) Versus Masked (Blinded) Microscopic Evaluation in Animal Toxicity Studies Brad Bolon, Sabine Francke, Jessica M. Caverly Rae, Toxicologic Pathology	2022	11

Page 1